Products for Research Use Only
RegisterLogin

Lacutamab

CAT: 0804-HY-P99369-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99369-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Lacutamab (IPH4102) is a humanizedized monoclonal antibody (mAb) directed against the immune receptor molecule KIR3DL2, produced by recombinant technology in CHO cells. Lacutamab can be used in research of cutaneous T-cell lymphoma[1].
CAS Number
2187368-16-5
Product Name Alternative
IPH 4102; Anti-KIR3DL2/CD158k Reference Antibody (lacutamab)
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/lacutamab.html
Purity
99.90
Solubility
10 mM in DMSO
Smiles
[Lacutamab]
Molecular Weight
(144.52 kDa)
References & Citations
[1]Van Der Weyden C, et, al. IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma. Expert Opin Investig Drugs. 2018 Aug;27 (8) :691-697.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
MBS5819211Lacutamab
GTR18333605-01Lacutamab Antibody
591946Lacutamab (KIR3DL2)
MBS1563739-01Research Grade Lacutamab
E55B0406Lacutamab (Reference antibody)
ICH5619-50mgLacutamab Biosimilar - Research Grade
C00225-01Lacutamab (Anti-KIR3DL2 / CD158k)
A138281Lacutamab Biosimilar (Monoclonal, IgG1)
GTR18697811-01Lacutamab Human Monoclonal Antibody
GTR18780620-01(Lacutamab) Biosimilar Reference Antibody

Popular Products